AsepticSure hospital sterilisation system trials underway
Medizone of San Francisco has started the first in a series of trials designed to confirm that its AsepticSure sterilisation system can eliminate hospital-based bacterial pathogens. Dr. Dick Zoutman, an expert in medical microbiology and hospital infections, is leading these trials.
Medizone's director of medical affairs, Dr Michael Shannon, said: ‘If these trials successfully demonstrate that our equipment and protocols are fully effective at eliminating the bacteria being tested, as we anticipate, the results will constitute a powerful signal to the healthcare community that a safe and inexpensive solution will soon be available to effectively address a problem which last year resulted in more than 60,000 hospital acquired infectious disease deaths in North America alone.’
Medizone expects to release the results of these first trials next month, following the filing of new patent applications.
Contact {encode="operations@medizoneint.com" title="operations@medizoneint.com"} www.medizoneint.com
